HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Has “Ample Regulatory Authority” To Oversee Cosmetics – McNeil

This article was originally published in The Rose Sheet

Executive Summary

FDA has "ample regulatory authority" to take action against cosmetic manufacturers who cross the line into making illegal drug claims, and should not resort to changing the regulatory status of certain categories of products, McNeil Personal Products Company states in comments to the agency
Advertisement

Related Content

AHA, BHA Products Are Cosmetics Based On Legal Precedent – CTFA
Are Wrinkle Treatments With AHAs, BHAs OTCs? FDA Issues Call For Data
Are Wrinkle Treatments With AHAs, BHAs OTCs? FDA Issues Call For Data
Advertisement
UsernamePublicRestriction

Register

RS012296

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel